Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neurochem Int ; 44(1): 45-52, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12963087

RESUMO

D-2-Hydroxyglutaric acid (DGA) is the biochemical hallmark of patients affected by the neurometabolic disorder known as D-2-hydroxyglutaric aciduria (DHGA). Although this disease is predominantly characterized by severe neurological findings, the underlying mechanisms of brain injury are virtually unknown. In the present study, we investigated the effect of DGA on total, cytosolic, and mitochondrial creatine kinase (CK) activities from cerebral cortex of 30-day-old Wistar rats. Total CK activity (tCK) was measured in whole cell homogenates, whereas cytosolic and mitochondrial activities were measured in the cytosolic and mitochondrial preparations from cerebral cortex. We verified that CK activities were significantly inhibited by DGA (11-34% inhibition) at concentrations as low as 0.25 mM, being the mitochondrial fraction the most affected activity. Kinetic studies revealed that the inhibitory effect of DGA was non-competitive in relation to phosphocreatine. We also observed that this inhibition was fully prevented by pre-incubation of the homogenates with reduced glutathione, suggesting that the inhibitory effect of DGA on tCK activity is possibly mediated by oxidation of essential thiol groups of the enzyme. Considering the importance of CK activity for brain metabolism homeostasis, our results suggest that inhibition of this enzyme by increased levels of DGA may be related to the neurodegeneration of patients affected by DHGA.


Assuntos
Córtex Cerebral/enzimologia , Creatina Quinase/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Glutaratos/farmacologia , Animais , Ácido Ascórbico/farmacologia , Córtex Cerebral/efeitos dos fármacos , Creatina Quinase/metabolismo , Citosol/efeitos dos fármacos , Citosol/enzimologia , Sequestradores de Radicais Livres/farmacologia , Glutationa/farmacologia , Técnicas In Vitro , Cinética , Masculino , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/enzimologia , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Oxirredução , Ratos , Ratos Wistar , Vitamina E/farmacologia
2.
Int J Dev Neurosci ; 21(4): 217-24, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12781789

RESUMO

L-2-Hydroxyglutaric acid (LGA) is the biochemical hallmark of patients affected by the neurometabolic disorder known as L-2-hydroxyglutaric aciduria (LHGA). Although this disorder is predominantly characterized by severe neurological findings and pronounced cerebellum atrophy, the neurotoxic mechanisms of brain injury are virtually unknown. In the present study, we investigated the effect of LGA, at 0.25-5mM concentrations, on total creatine kinase (tCK) activity from cerebellum, cerebral cortex, cardiac muscle and skeletal muscle homogenates of 30-day-old Wistar rats. CK activity was measured also in the cytosolic (Cy-CK) and mitochondrial (Mi-CK) fractions from cerebellum. We verified that tCK activity was significantly inhibited by LGA in the cerebellum, but not in cerebral cortex, cardiac muscle and skeletal muscle. Furthermore, CK activity from the mitochondrial fraction was inhibited by LGA, whereas that from the cytosolic fraction of cerebellum was not affected by the acid. Kinetic studies revealed that the inhibitory effect of LGA on Mi-CK was non-competitive in relation to phosphocreatine. Finally, we verified that the inhibitory effect of LGA on tCK was fully prevented by pre-incubation of the homogenates with reduced glutathione (GSH), suggesting that this inhibition is possibly mediated by oxidation of essential thiol groups of the enzyme. Considering the importance of creatine kinase activity for energy homeostasis, our results suggest that the selective inhibition of this enzyme activity by increased levels of LGA could be possibly related to the cerebellar degeneration characteristically found in patients affected by L-2-hydroxyglutaric aciduria.


Assuntos
Cerebelo/embriologia , Cerebelo/enzimologia , Creatina Quinase/antagonistas & inibidores , Creatina Quinase/metabolismo , Glutaratos/farmacologia , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Animais , Ácido Ascórbico/farmacologia , Encefalopatias Metabólicas Congênitas/metabolismo , Cerebelo/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/embriologia , Córtex Cerebral/enzimologia , Creatina Quinase Mitocondrial , Glutationa/farmacologia , Coração/efeitos dos fármacos , Coração/embriologia , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/enzimologia , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/embriologia , Músculo Esquelético/enzimologia , Miocárdio/enzimologia , NG-Nitroarginina Metil Éster/farmacologia , Especificidade de Órgãos , Ratos , Ratos Wistar , alfa-Tocoferol/farmacologia
3.
Neurochem Res ; 28(9): 1329-37, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12938854

RESUMO

D-2-Hydroxyglutaric aciduria (DHGA) is a neurometabolic disorder biochemically characterized by tissue accumulation and excretion of high amounts of D-2-hydroxyglutaric acid (DGA). Although the affected patients have predominantly severe neurological findings, the underlying mechanisms of brain injury are virtually unknown. In previous studies we have demonstrated that DGA, at concentrations as low as 0.25 mM, significantly decreased creatine kinase activity and other parameters of energy metabolism in cerebral cortex of young rats. In the present study, we investigated the effect of DGA (0.25-5 mM) on total creatine kinase (tCK) activity, as well as on CK activity in cytosolic (Cy-CK) and mitochondrial (Mi-CK) preparations from cerebellum of 30-day-old Wistar rats in order to test whether the inhibitory effect of DGA on CK was tissue specific. We verified that tCK (22% inhibition) and Mi-CK (40% inhibition) activities were moderately inhibited by DGA at concentrations of 2.5 mM and higher, in contrast to Cy-CK, which was not affected by the acid. Kinetic studies revealed that the inhibitory effect of DGA was noncompetitive in relation to phosphocreatine. We also observed that this inhibition was fully prevented by preincubation of the homogenates with reduced glutathione, suggesting that the inhibition of CK activity by DGA is possibly mediated by modification of essential thiol groups of the enzyme. Our present results therefore demonstrate a relatively weak inhibitory effect of DGA on cerebellum Mi-CK activity, as compared to that provoked in cerebral cortex, and may possibly be related to the neuropathology of DHGA, characterized by cerebral cortex abnormalities.


Assuntos
Cerebelo/efeitos dos fármacos , Creatina Quinase/metabolismo , Glutaratos/farmacologia , Mitocôndrias/efeitos dos fármacos , Animais , Antioxidantes/farmacologia , Ácido Ascórbico/farmacologia , Cerebelo/enzimologia , Cerebelo/ultraestrutura , Cromanos/farmacologia , Sequestradores de Radicais Livres/farmacologia , Glutaratos/química , Glutationa/farmacologia , Técnicas In Vitro , Isoenzimas/metabolismo , Mitocôndrias/enzimologia , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Especificidade de Órgãos , Ratos , Ratos Wistar , Estereoisomerismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA